Skip to content

News
 

SB 1064 (Alquist): California Stem Cell Research and Cures Act

Author: Elaine Alquist (D - Santa Clara)
CHI Position: NEUTRAL

Summary: Imposes additional oversight and transparency requirements on the California Institute for Regenerative Medicine (CIRM), revises CIRM's intellectual property (IP) standards with regard to licensing revenue and drug discount access plans for low income and uninsured Californians, and requires revenues from CIRM's IP agreements to be deposited in the state General Fund.


Current Bill Text, Status, and Location

CHI Letter of Neutrality for SB 1064